Treatment of Ptosis as a Complication of Botulinum Toxin Injection


In this case report, we present one of the complications of botulinum toxin injection. Botulinum toxin injection could be used in the treatment of migraine headaches and this use could be complicated by ptosis. Botulinum toxin type A was injected into the frontalis, orbicularis oculi, corrugator supercillis, and temporalis muscles bilateral, as well as into the procerus muscle, in a patient with chronic migraine headache. Three days later the patient developed ptosis, conjunctival injection and pain initially in one eye, later involving both eyes. This complication was successfully treated after 9 days of instilling apraclonidine 0.5% ophthalmic solution and dexamethasone 0.1%/tobramycin 0.3% ophthalmic suspension into both eyes.

Related Articles

A New Minimally Invasive Procedure for Muscle, Back,
Neck Pain and Radiculopathy – The Myofascial Nerve

This is the first description of a procedure targeting the myofascial tissues since Janet Travell’s
description of myofascial trigger points in 1942. However unlike trigger point injections, this
minimally invasive myofascial nerve injection is performed differently and targets the myofascial
tissues, peripheral innervations, posterior spinal structures and spinal nerve roots at the same
time. It is different from a trigger point injection that aims to block trigger points within a muscle.
Prolonged standing or sitting, posture and other multiple factors can create recurrent injuries
with attendant inflammation and episodically aggravate pain. Thus there is a need for a simple
intervention technique that can be performed from the medical clinic to the battlefield to quickly
relieve inflammation and prevent chronic pain.